piotr-adamowicz-shutterstock-com-gavel-
Piotr Adamowicz / Shutterstock.com
15 August 2016Americas

US court says epilepsy patent is valid

The US District Court for the District of Delaware has ruled that pharmaceutical company UCB’s patent covering epilepsy drug Vimpat (lacosamide) is valid, after it was challenged by generic drug makers.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk